Karyopharm announces presentation of new xpovio® (selinexor) data in patients with acute myeloid leukemia at the american society of hematology 2020 annual meeting

Newton, mass., dec. 7, 2020 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced an oral presentation highlighting data related to xpovio® (selinexor), the company's first-in-class, oral...
KPTI Ratings Summary
KPTI Quant Ranking